Skip to content
Screener

Baxter International BAX Q3 2026 earnings

Reported October 29, 2026 · Before market open

Revenue$3.0BBeat by $67.9M
EPS$0.58Beat by $0.06
Revenue estimate$2.9B
EPS estimate$0.52
“We delivered a strong third quarter, with growth across all segments and divisions globally. We continue to make steady progress stabilizing the business, strengthening the balance sheet and driving continuous improvement. Our results reinforce our confidence in this direction as we build a stronger foundation for sustainable growth and long-term value creation.”
Andrew Hider

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$3.0B+5.0%
Gross profit$994.0M+4.6%
Operating income$225.0M+30.8%
Net income$294.0M+739%
EPS (diluted)$0.57+733%

Balance sheet

See full
Cash & equivalents$2.0B+14.3%
Total debt$206.0M-3.7%
Total equity$6.5B-10.2%
Total assets$19.4B-7.8%

Cash flow

See full
Operating cash flow$558.0M+135%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$12.15B+23.5%
Enterprise value$10.38B+24.7%
P/S1.1×+0.2×

Profitability

See full
Gross margin30.1%-4.0pp
Operating margin-1.9%—
Net margin-6.2%-489pp

Returns & leverage

See full
Return on equity-10.5%-42.3pp
Debt / equity0×0.0×
Current ratio1.8×0.0×

Segments

By product

See full
Infusion Therapies & Platforms$1.8B—
Care & Connectivity Solutions$498.0M+5.3%
Advanced Surgery$342.0M+11.8%
Front Line Care$308.0M+2.7%

By segment

See full
Medical Products & Therapies$2.1B+58.2%
Healthcare Systems & Technologies$806.0M+4.3%

By geography

See full
International$1.4B—

FAQ

When did Baxter International report Q3 2026 earnings?
Baxter International (BAX) reported Q3 2026 earnings on October 29, 2026 before market open.
What were Baxter International's Q3 2026 revenue and EPS?
Baxter International reported revenue of $3.0B and eps of $0.58 for Q3 2026.
Did Baxter International beat estimates in Q3 2026?
Revenue beat the consensus estimate of $2.9B by $67.9M. EPS beat the consensus estimate of $0.52 by $0.06.
How did Baxter International's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.0% from $2.8B a year earlier and eps declined 15.9% from $0.69.
Where can I find Baxter International's Q3 2026 SEC filings?
You can read the 8-K earnings release (0000010456-26-000004) and the 10-Q periodic report (0001628280-26-068278) directly on SEC EDGAR. The filing index links above go to sec.gov.